Page last updated: 2024-10-30

mecamylamine and Sciatica

mecamylamine has been researched along with Sciatica in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Sciatica: A condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY (involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT); or lesions of the CAUDA EQUINA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Cesare Mannelli, L1
Ghelardini, C1
Calvani, M1
Nicolai, R1
Mosconi, L1
Toscano, A1
Pacini, A1
Bartolini, A1

Other Studies

1 other study available for mecamylamine and Sciatica

ArticleYear
Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.
    Journal of neuroscience research, 2009, Volume: 87, Issue:1

    Topics: Acetylcarnitine; Animals; Apoptosis; Atropine; Caspase 3; Cytochromes c; Disease Models, Animal; In

2009